Meadow Creek Investment Management’s BeOne Medicines Ltd ONC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2019
Q3
$58K Hold
476
﹤0.01% 1256
2019
Q2
$59K Buy
476
+68
+17% +$8.63K ﹤0.01% 1267
2019
Q1
$54K Hold
408
﹤0.01% 1265
2018
Q4
$57K Buy
+408
New +$54.1K ﹤0.01% 1213

Other funds holding ONC

Meadow Creek Investment Management's ONC Position: Q3 2019 in Review

Meadow Creek Investment Management held its BeOne Medicines Ltd (ONC) position steady in Q3 2019 at 476 shares worth $58K. The position accounts for ﹤0.01% of the portfolio, ranked #1256.

Meadow Creek Investment Management first reported a position in ONC in Q4 2018 and has held it in 4 quarters since. The position peaked at $59K in Q2 2019. 196 funds tracked by Wall St. Rank hold ONC as of Q3 2019.

  • Meadow Creek Investment Management held 476 shares of BeOne Medicines Ltd worth $58K as of Q3 2019.
  • Meadow Creek Investment Management left its BeOne Medicines Ltd share count unchanged in Q3 2019.
  • BeOne Medicines Ltd made up ﹤0.01% of Meadow Creek Investment Management's portfolio in Q3 2019, its #1256 holding.
  • Meadow Creek Investment Management first reported a position in BeOne Medicines Ltd in Q4 2018 and has held it in 4 quarters since.
  • Meadow Creek Investment Management's BeOne Medicines Ltd position peaked at $59K in Q2 2019.
  • 196 funds tracked by Wall St. Rank held BeOne Medicines Ltd as of Q3 2019.

Based on Meadow Creek Investment Management's 13F filing for Q3 2019, filed 14 Nov 2019.